Oral drops: Each 1ml (30 drops) contains 1mg Ergoloid mesylates.


A proportion of individuals over 60 who manifest signs and symptoms of an idiopathic decline in mental capacity (i.e., cognitive and interpersonal skills, mood, self-care, apparent motivation) can experience some symptomatic relief upon treatment with ergoloid mesylates preparations.

It appears, however, that those individuals who do respond come from groups of patients who would be considered clinically to suffer from some ill-defined process related to aging or to have some underlying dementing condition (i.e., primary progressive dementia, Alzheimer’s dementia, senile onset, multi-infarct dementia).

Ergoloid mesylates preparations are not indicated in the treatment of acute or chronic psychosis.


1 mg three times a day.

Alleviation of symptoms is usually gradual and results may not be observed for 3-4 weeks.


Oral drops: Bottle of 30ml.